Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients
暂无分享,去创建一个
G. Raimondo | G. Squadrito | T. Pollicino | A. Craxì | S. Maimone | G. Isgró | V. Marco | D. Ferraro | R. Di Stefano | S. Brancatelli
[1] R. Tedder,et al. Antiviral Resistance Mutations Potentiate hepatitis B virus Immune Evasion through Disruption of its Surface Antigen a Determinant , 2008, Antiviral therapy.
[2] A. Lok,et al. Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. , 2008, Journal of hepatology.
[3] Jean-Michel Pawlotsky,et al. Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. , 2008, Gastroenterology.
[4] K. Borroto-Esoda,et al. Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir. , 2007, The Journal of infectious diseases.
[5] M. Buti,et al. Antiviral‐resistant hepatitis B virus: can we prevent this monster from growing? , 2007, Journal of viral hepatitis.
[6] K. Borroto-Esoda,et al. Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials. , 2007, Journal of hepatology.
[7] Angeline Bartholomeusz,et al. Antiviral drug‐resistant HBV: Standardization of nomenclature and assays and recommendations for management , 2007, Hepatology.
[8] T. Liang,et al. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. , 2007, Gastroenterology.
[9] J. Hoofnagle,et al. Management of hepatitis B: Summary of a clinical research workshop , 2007, Hepatology.
[10] M. Levrero,et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma , 2007, Hepatology.
[11] B. Rodés,et al. Mutations affecting the replication capacity of the hepatitis B virus , 2006, Journal of viral hepatitis.
[12] S. Locarnini,et al. Antiviral drug resistance: clinical consequences and molecular aspects. , 2006, Seminars in liver disease.
[13] M. Helm,et al. Variant of hepatitis B virus with primary resistance to adefovir. , 2006, The New England journal of medicine.
[14] Angeline Bartholomeusz,et al. HBV drug resistance: mechanisms, detection and interpretation. , 2006, Journal of hepatology.
[15] S. Locarnini,et al. Cellular and virological mechanisms of HBV drug resistance. , 2006, Journal of hepatology.
[16] A. Bartholomeusz,et al. Hepatitis B virus mutations associated with antiviral therapy , 2006, Journal of medical virology.
[17] J. Pawlotsky. The concept of hepatitis B virus mutant escape. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[18] B. Tehan,et al. Comparisons of the Hbv and HIV Polymerase, and Antiviral Resistance Mutations , 2003, Antiviral therapy.
[19] J. Torresi. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[20] M. Manns,et al. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. , 2002, Virology.
[21] D. Jackson,et al. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. , 2002, Virology.
[22] M. Manns,et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. , 2002, Gastroenterology.
[23] W. Delaney,et al. Resistance of Hepatitis B Virus to Antiviral Drugs: Current Aspects and Directions for Future Investigation , 2001, Antiviral chemistry & chemotherapy.
[24] M. Manns,et al. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. , 1997, Gastroenterology.
[25] W. Carman,et al. The clinical significance of surface antigen variants of hepatitis B virus , 1997, Journal of viral hepatitis.
[26] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[27] F. Chisari,et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.
[28] F. Galibert,et al. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli , 1979, Nature.